Enochian Biosciences Stock Price, News & Analysis
Company Description
Enochian Biosciences (NASDAQ: ENOB) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $44.6M.
ENOB stock has gained 140.9% over the past year.
This page provides a comprehensive overview of ENOB stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Enochian Biosciences (ENOB) stock. Over the past 12 months, the stock has gained 140.9%. At a market capitalization of $44.6M, ENOB is classified as a micro-cap stock with approximately 63.7M shares outstanding.
Latest News
Enochian Biosciences has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 5 with negative movement. Key topics include fda approval. View all ENOB news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
ENOB Company Profile & Sector Positioning
Enochian Biosciences (ENOB) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ.
Investors comparing ENOB often look at related companies in the same sector, including Verrica Pharmaceuticals (VRCA), Outlook Therapeutics Inc (OTLK), Plus Therapeutics Inc (PSTV), Annovis Bio Inc (ANVS), and Telomir Pharms (TELO). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate ENOB's relative position within its industry.